AstraZeneca PLC (AZN) stock
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca operating margin
Operating margin is operating income as a percentage of revenue.
For fiscal 2025 it was 23.4%, against 18.5% the year before. The highest annual figure on record is 23.4% in fiscal 2025.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 23.4% | +4.9 |
| FY2024 | Dec 31, 2024 | 18.5% | +0.6 |
| FY2023 | Dec 31, 2023 | 17.9% | +9.4 |
| FY2022 | Dec 31, 2022 | 8.5% | +5.6 |
| FY2021 | Dec 31, 2021 | 2.8% | −16.6 |
| FY2020 | Dec 31, 2020 | 19.4% | +7.4 |
| FY2019 | Dec 31, 2019 | 12.0% | −3.3 |
| FY2018 | Dec 31, 2018 | 15.3% | −1.0 |
| FY2017 | Dec 31, 2017 | 16.4% | −4.9 |
| FY2016 | Dec 31, 2016 | 21.3% | +4.7 |
| FY2015 | Dec 31, 2015 | 16.7% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 20.6% | +15.6 |
| Q2 FY2025 | Jun 30, 2025 | 24.3% | +10.6 |
| Q2 FY2024 | Jun 30, 2024 | 21.2% | +0.8 |
| Q2 FY2023 | Jun 30, 2023 | 21.5% | +13.0 |
| Q2 FY2022 | Jun 30, 2022 | 5.0% | −9.8 |
| Q2 FY2021 | Jun 30, 2021 | 13.7% | −5.0 |
| Q2 FY2020 | Jun 30, 2020 | 20.5% | – |
| Q2 FY2019 | Jun 30, 2019 | 8.5% | – |
| Q2 FY2018 | Jun 30, 2018 | 14.8% | – |
| Q2 FY2017 | Jun 30, 2017 | 18.7% | – |
See a number that looks wrong?